Brain Metastases from Ovarian Carcinoma
Joint Authors
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-13, 13 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-12-01
Country of Publication
Egypt
No. of Pages
13
Main Subjects
Abstract EN
This paper will focus on knowledge related to brain metastases from ovarian carcinoma.
So far, less than 600 cases were documented in the literature with an incidence among ovarian carcinoma patients ranging from 0.29% to 11.6%.
The ovarian carcinoma was usually an advanced-stage epithelial serous carcinoma, and the median interval between diagnosis of ovarian carcinoma and brain metastases was 2 years.
Most often, brain metastases, affected the cerebrum, were multiple and part of a disseminated disease.
Treatment of brain metastasis has evolved over the years from whole brain radiotherapy (WBRT) only to multimodal therapy including surgical resection or stereotactic radiosurgery followed by WBRT and/or chemotherapy.
The median survival after diagnosis of brain metastases was 6 months; nevertheless, a significantly better survival was achieved with multimodal therapy compared to WBRT only.
It is suggested that brain imaging studies should be included in the followup of patients after treatment for ovarian carcinoma.
American Psychological Association (APA)
Piura, Ettie& Piura, Benjamin. 2011. Brain Metastases from Ovarian Carcinoma. ISRN Oncology،Vol. 2011, no. 2011, pp.1-13.
https://search.emarefa.net/detail/BIM-478800
Modern Language Association (MLA)
Piura, Ettie& Piura, Benjamin. Brain Metastases from Ovarian Carcinoma. ISRN Oncology No. 2011 (2011), pp.1-13.
https://search.emarefa.net/detail/BIM-478800
American Medical Association (AMA)
Piura, Ettie& Piura, Benjamin. Brain Metastases from Ovarian Carcinoma. ISRN Oncology. 2011. Vol. 2011, no. 2011, pp.1-13.
https://search.emarefa.net/detail/BIM-478800
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-478800